Back
Enanta Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
ENTA
Sponsored
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.
Sell
34
ENTA
Enanta Pharmaceuticals
Last Price:
12.34
Seasonality Move:
-6.03%
7 Day Trial
ALL ACCESS PASS
$
7
My #1 Coin is...
All the details are on the next page.Enanta Pharmaceuticals Price Quote
$12.34
-0.03 (-1.12%)
(Updated: April 27, 2024 at 6:02 AM ET)
Enanta Pharmaceuticals Key Stats
Sell
34
Enanta Pharmaceuticals (ENTA)
is a Sell
Day range:
$12.20 - $12.65
52-week range:
$8.08 - $37.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.54
P/B ratio:
1.36%
Volume:
67K
Avg. volume:
211.4K
1-year change:
-64.2%
Market cap:
$261.7M
Revenue:
$79.2M
EPS:
$-6.56
How Much Does Enanta Pharmaceuticals Make?
-
How Much Are Enanta Pharmaceuticals's Sales Annually?
ENTA Revenues are $79.2M -
How Much Profit Does Enanta Pharmaceuticals's Make A Year?
ENTA net income is -$133.8M
Is Enanta Pharmaceuticals Growing As A Company?
-
What Is Enanta Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.24% -
What Is Enanta Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Enanta Pharmaceuticals Stock Price Performance
-
Did Enanta Pharmaceuticals Stock Go Up Last Month?
Enanta Pharmaceuticals share price went down by -22.45% last month -
Did ENTA's Share Price Rise Over The Last Year?
ENTA share price fell by -64.2% over the past 1 year
What Is Enanta Pharmaceuticals 52-Week High & Low?
-
What Is Enanta Pharmaceuticals’s 52-Week High Share Price?
Enanta Pharmaceuticals has traded as high as $37.75 over the past 52 weeks -
What Is Enanta Pharmaceuticals’s 52-Week Low Share Price?
Enanta Pharmaceuticals has traded as low as $8.08 over the past 52 weeks
Enanta Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Enanta Pharmaceuticals?
-
How Much Debt Does Enanta Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Enanta Pharmaceuticals Have?
Cash and short term investments quarterly total is $337.2M -
What Is Enanta Pharmaceuticals’s Book Value Per Share?
Book value per share is 9.07
Is Enanta Pharmaceuticals Cash Flow Positive?
-
What Is ENTA Cash Flow From Operations?
Cash flow from operations (TTM) is -$92.5M -
What Is Enanta Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $190.5M -
What Is Enanta Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$100.3M
Enanta Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
ENTA return on invested capital is -56.81% -
What Is Enanta Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -33.55% -
What Is ENTA Return On Equity?
ROE is a measure of profitability and is -56.81%
Enanta Pharmaceuticals Earnings Date & Stock Price
-
What Is Enanta Pharmaceuticals's Stock Price Today?
A single share of ENTA can be purchased today for 12.37 -
What Is Enanta Pharmaceuticals’s Stock Symbol?
Enanta Pharmaceuticals trades on the nasdaq under the ticker symbol: ENTA -
When Is Enanta Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Enanta Pharmaceuticals is scheduled on May 8, 2024 -
When Is ENTA's next ex-dividend date?
Enanta Pharmaceuticals's next ex-dividend date is April 28, 2024 -
How To Buy Enanta Pharmaceuticals Stock?
You can buy Enanta Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Enanta Pharmaceuticals Competitors
-
Who Are Enanta Pharmaceuticals's Competitors?
Below is a list of companies who compete with Enanta Pharmaceuticals or are related in some way:
Enanta Pharmaceuticals Dividend Yield
Data Unavailable
Enanta Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -28.87% |
Revenue: | -23.67% | -17.97% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 0 |
Price Target: | 20.88 |
Upside from Last Price: | 68.76% |